| | | | | |
INBX Inhibrx Biosciences, Inc. Common Stock | $98,2490 | +3,84% | $1,44B | $150,40K | |
TMP Tompkins Financial Corporation | $98,1170 | -2,12% | $1,44B | $25,41K | |
BRUN Boost Run Inc. Class A Common Stock | $19,3940 | -3,66% | $1,44B | $1,63M | |
TWFG TWFG, Inc. Common Stock | $27,2800 | +1,87% | $1,44B | $76,82K | |
PCT PureCycle Technologies, Inc. Common stock | $7,2650 | +5,60% | $1,44B | $1,44M | |
REX REX American Resources Corp. | $44,0750 | -0,10% | $1,43B | $31,19K | |
NNNN Anbio Biotechnology Class A Ordinary Shares | $7,8600 | -5,87% | $1,43B | $35,18K | |
BTT BlackRock Municipal 2030 Target Term Trust | $22,6200 | +0,13% | $1,43B | $9,72K | |
ADNT Adient plc Ordinary Shares | $19,9100 | +2,21% | $1,43B | $142,59K | |
KALV KalVista Pharmaceuticals, Inc. Common Stock | $26,9900 | -0,04% | $1,43B | $1,83M | |
| $37,4100 | -0,40% | $1,43B | $469,19K | |
EMAT Evolution Metals & Technologies Corp. Common Stock | $2,8900 | -7,37% | $1,43B | $384,97K | |
DAO Youdao, Inc. American Depositary Shares, each representing one Class A Ordinary Share | $16,8340 | -1,03% | $1,42B | $60,01K | |
REPL Replimune Group, Inc. | $14,9130 | -4,28% | $1,42B | $1,86M | |
HCSG Healthcare Services Group | $23,1290 | +5,42% | $1,42B | $254,72K | |
